Compare · head to head
Clinuvel Pharmaceuticals vs Dong-A ST
Clinuvel Pharmaceuticals ranks higher overall — 360 rank 93 vs 39.
Dong-A ST leads on Value (57 vs 51) and Growth (60 vs 46). Clinuvel Pharmaceuticals leads on Quality (77 vs 57), Safety (69 vs 19) and Sentiment (57 vs 44).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Australia | South Korea |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Pharmaceuticals |
| Size | Small | Small |
| ISIN | AU000000CUV3 | KR7170900005 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 93 | 39 |
| Value | 51 | 57 |
| Quality | 77 | 57 |
| Growth | 46 | 60 |
| Safety | 69 | 19 |
| Sentiment | 57 | 44 |
| Quality details | ||
| Profitability | 94 | 57 |
| Cash Truth | 59 | 58 |
Clinuvel Pharmaceuticals vs Zai LabClinuvel Pharmaceuticals vs MesoblastClinuvel Pharmaceuticals vs J. B. Chemicals & PharmaceuticalsClinuvel Pharmaceuticals vs Bukwang PharmaceuticalAdd a third stock →
Full analyses: Clinuvel Pharmaceuticals · Dong-A ST
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100